Type your tag names separated by a space and hit enter

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation ID - 453180 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453180/all/Cannabinoid_type_1_receptor_antagonists__rimonabant__for_smoking_cessation PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -